He-Ne激光血管内照射治疗缺血性脑血管病  被引量:1

Therapeutic Effects of He-Ne Laser Intravascular Irradiation for Ischemic Cerebrovascular Disease

在线阅读下载全文

作  者:李云斌[1] 徐淑贤[2] 乐秀英[1] 陈翠珍[1] 李新胜[3] 

机构地区:[1]东南大学附属中大医院康复医学科,江苏南京210009 [2]哈尔滨医科大学附属第一医院社区医学科 [3]东南大学附属中大医院脑电图室,江苏南京210009

出  处:《中国康复》2003年第6期360-362,共3页Chinese Journal of Rehabilitation

摘  要:目的 :临床观察He Ne激光血管内照射疗法 (ILIB)对缺血性脑血管病的疗效。方法 :12 0例确诊为缺血性脑血管病的患者随机分为 2组 ,均按神经科常规药物治疗 ,ILIB组同时加用ILIB治疗 ,每日或隔日 1次 ,10次为 1疗程。 2组治疗前后进行经颅多普勒 (TCD)与脑电地形图 (BEAM)检测比较。结果 :ILIB组痊愈率 31 7% ,临床总有效率96 7% ,明显高于常规组 (P <0 .0 1) ;治疗前后 2组TCD与BEAM检测比较 ,差异有显著性 (P <0 .0 1)。结论 :缺血性脑血管病在常规药物治疗基础上加用ILIB可取得更好的治疗效果。TCD与BEAM的检测是评价ILIB治疗缺血性脑血管病的一项敏感指标。Objective: To observe the effectiveness of low energy of He-Ne laser intravascular irradiation (ILIB) in the treatment of ischemic cerebrovascular disease. Methods: Eighty patients with ischemic cerebrovascular disease were randomly divided into two groups: the routine treatment group (n=60) receiving the treatment of conventional drugs and ILIB therapy group (n=60) receiving ILIB of low energy, once every day or every other day for 10 times besides the routine treatment. The changes of TCD and BEAM were examined and compared before and after treatment. Results: The recovery rate and total effective rate in ILIB therapy group after a course of treatment was 31.7 % and 96.7 % respectively, significantly higher than in routine treatment group (P<0.01). There was significant difference in the changes of TCD and BEAM between the two groups (P<0.01). Conclusion: Routine drugs in combination with ILIB could get better effectiveness in the treatment of ischemic cerebrovascular disease. Examination of TCD and BEAM is one of useful methods for evaluating the efficacy of ILIB in the treatment of ischemic cerebrovascular disease.

关 键 词:HE-NE激光 经颅多普勒 脑电地形图 缺血性脑血管病 治疗 

分 类 号:R454.2[医药卫生—治疗学] R743[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象